SCHEMBL29953052

SCHEMBL29953052

O=Cc1cc(O)c2ncccc2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 1/20 0.54
KDM4E B2RXH2 12/20 0.54
NPC1 O15118 8/20 0.54
RAB9A P51151 7/20 0.54
MAPT P10636 1/20 0.54
PKM P14618 1/20 0.54
NFKB1 P19838 1/20 0.54
HTT P42858 1/20 0.54
CASP6 P55212 1/20 0.54
NFKB2 Q00653 1/20 0.54
RELA Q04206 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
L3MBTL1 Q9Y468 11/20 0.53
COMT P21964 2/20 0.52
MMP2 P08253 1/20 0.52
CHRM1 P11229 1/20 0.52
TSHR P16473 1/20 0.52
ADRA1A P35348 1/20 0.52
METAP2 P50579 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28592203 1.00 ERN1 (0.54) ERN1KDM4ENPC1RAB9AMAPT
SCHEMBL23928250 0.83 KDM4E (0.53) ERN1KDM4ENPC1RAB9AMAPT
SCHEMBL1223838 0.79 CCR1 (0.54) ERN1KDM4EMAPTNFKB1HTT
SCHEMBL13849039 0.79 ERN1 (0.42) ERN1KDM4ENPC1RAB9AMAPT
SCHEMBL1225086 0.79 CCR1 (0.50) ERN1KDM4EMAPTNFKB1HTT
SCHEMBL1225281 0.79 TRPM5 (0.46) ERN1KDM4EMAPTNFKB1HTT
SCHEMBL4037328 0.79 ERN1 (0.42) ERN1KDM4ENPC1RAB9AMAPT
Oxyquinoline SCHEMBL8525546 0.77 TSHR (0.68) ERN1KDM4ENPC1RAB9AMAPT
SCHEMBL20176001 0.76 COMT (0.59) KDM4ENPC1RAB9AMAPTPKM
SCHEMBL28490536 0.76 KDM4E (0.57) KDM4ENPC1COMTMMP2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240327410-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2024-10-03 US disclosed
US-11993601-B2 Monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV 2024-05-28 US disclosed
US-20230242531-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2023-08-03 US disclosed
US-11597728-B2 Monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2023-03-07 US disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
US-20220315583-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2022-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242531-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP ERN1 3814/4885KDM4E 2800/4885NPC1 826/4885
US-11993601-B2 Monoacylglycerol lipase modulators MGLL, LPL, PNLIP ERN1 3814/4885KDM4E 2800/4885NPC1 826/4885
US-11597728-B2 Monoacylglycerol lipase modulators MGLL, LPL, PNLIP ERN1 3814/4885KDM4E 2800/4885NPC1 826/4885
US-20240327410-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP ERN1 3814/4885KDM4E 2800/4885NPC1 826/4885
US-20220315583-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP ERN1 3814/4885KDM4E 2800/4885NPC1 826/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.